Compare BridgeBio Pharma Inc (BBIO) vs Huntington Bancshares Incorporated (HBAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Huntington Bancshares Incorporated — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Huntington Bancshares Incorporated trades at $17.94 (market cap $35.93B). The key difference: Huntington Bancshares Incorporated is far larger — about 2.2× BridgeBio Pharma Inc's market cap, and Huntington Bancshares Incorporated pays a 3.49% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | HBAN | |
|---|---|---|
Market Cap | $16.36B | $35.93B |
Sector | Health | Financials |
52-Week High | $90.17 | $19.27 |
52-Week Low | $47.29 | $15.02 |
Enterprise Value | $18.14B | — |
Dividend Yield | — | 3.49% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →
